Replies to post #236781 on Biotech Values

[swanlinbar]

$ITRM added more today.My largest holdings & a Keeper imho >First Sarissa Capital Management LP has filed Form SC 13D with SEC. Reporting 30.95% Ownership. then we have
RA Capital Management Discloses 18.9% Passive Stake In Iterum Therapeutics all within the last few months


ITRM Got to like this guys History > Corey Fishman
President and Chief Executive Officer ITRM

(Principal Executive Officer) Durata Pharma, a Corey Fishman led Pharma was sold to Actavis in 2014. Prior to the announcement of the sale the stock was trading at $12 and change. Actavis paid $23 per share or $675 million in the buyout,plus CVRs of up to an additional $5.00 per share in the event certain developmental or commercial milestones are met


Sarissa who took a 31% stake in ITRM is run by Alex Denner a Yale PhD who ran healthcare investments for Carl Icahn.
Why is Denner's hedge fund taking a 31% position in a Penny stock(under a buck) GLTA

Positive meeting with the FDA resulting in continued preparation for submission of the NDA filing in Q4 2020.